---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-076841"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:08:24.780375+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# TriSalus Life Sciences completes warrant exchange, issues 2.1M shares at 0.3 per warrant

## Summary
- Issued 2,110,366 shares of common stock in exchange for tendered warrants at a ratio of 0.3 shares per warrant.
- Exchange covered public warrants (TLSIW), private placement warrants, and working capital warrants.
- Warrant agreement amended with Continental Stock Transfer effective June 26, 2024.
- Offer and consent solicitation closed July 1, 2024; Oppenheimer served as dealer manager.

## SEC filing metadata
- accession: 0001104659-24-076841
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465924076841/0001104659-24-076841-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465924076841/tm2418573d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-076841
- JSON: https://secwatch.observer/filing/0001104659-24-076841.json
- Plain text: https://secwatch.observer/filing/0001104659-24-076841.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.